Spring Bk Pharms

SBPH NASDAQ
5.16
+0.10
+2.06%
交易中 12:57 07/19 EDT
开盘
5.09
昨收
5.06
最高
5.33
最低
5.09
成交量
1.33万
成交均量(3M)
9.91万
52周最高
15.00
52周最低
3.580
换手率
0.08%
市值
8,484.66万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Spring Bk Pharms SBPH股票价格,Spring Bk Pharms股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of a class of therapeutics using its small molecule nucleic acid hybrid (SMNH) chemistry platform. The Company is developing its SMNH product, SB 9200, for the treatment of viral diseases. The Company's SB 9200 selectively activates within infected cells the cellular proteins retinoic acid-inducible gene 1 (RIG-I) and nucleotide-binding oligomerization domain-containing protein 2 (NOD2) to inhibit viral replication and to cause the induction of intracellular interferon signaling pathways for antiviral defense. The Company is also developing a second SMNH product candidate, SB 11285, as an immunotherapeutic agent for the treatment of selected cancers through the activation of the STimulator of INterferon Genes (STING) pathway. The Company focuses on developing SB 9200 for the treatment of chronic hepatitis B virus (HBV).
展开 >

最近浏览

名称
价格
涨跌幅